SEC Form 5 · accession 0001250853-16-000131
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Chin
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 11:27 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2015 | G | 8,000 | $0.00 | D | 3,023,546 | D | |
| Common Stock | Mar 19, 2015 | G | 8,000 | $0.00 | A | 8,000 | I | By children |
| Common Stock | Jul 24, 2015 | G | 400,000 | $0.00 | D | 2,623,546 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved a gift of securities by the reporting person to his four children, who share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or any other purpose.
- F2This transaction involved a gift of securities by the reporting person to a family trust.